1. Home
  2. GPMT vs XLO Comparison

GPMT vs XLO Comparison

Compare GPMT & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Point Mortgage Trust Inc.

GPMT

Granite Point Mortgage Trust Inc.

HOLD

Current Price

$0.86

Market Cap

64.7M

Sector

Real Estate

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

N/A

Current Price

$9.09

Market Cap

56.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GPMT
XLO
Founded
2015
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.7M
56.9M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
GPMT
XLO
Price
$0.86
$9.09
Analyst Decision
Buy
Buy
Analyst Count
2
1
Target Price
$3.00
$28.00
AVG Volume (30 Days)
287.8K
8.3K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
12.99%
N/A
EPS Growth
73.58
N/A
EPS
N/A
N/A
Revenue
N/A
$43,766,000.00
Revenue This Year
$458.85
N/A
Revenue Next Year
$8.63
$168.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
589.88
52 Week Low
$0.84
$0.46
52 Week High
$3.06
$9.90

Technical Indicators

Market Signals
Indicator
GPMT
XLO
Relative Strength Index (RSI) 26.91 49.23
Support Level N/A $8.52
Resistance Level $1.56 $9.15
Average True Range (ATR) 0.05 0.29
MACD -0.01 0.00
Stochastic Oscillator 10.67 46.74

Price Performance

Historical Comparison
GPMT
XLO

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: